Nicotinell Tropenfrucht (Nicotine Polacrilex)

Nicotine Polacrilex, the active ingredient in Nicotinell Tropenfrucht, is a nicotine replacement therapy presented as an oromucosal formulation for buccal use. It is intended to aid adult smokers in managing withdrawal symptoms and reducing cravings during cessation attempts. The product delivers nicotine through the oral mucosa, providing a steady plasma concentration that mimics the nicotine delivery of cigarettes without the harmful tar and gases.

GNH USA supplies Nicotinell Tropenfrucht as a licensed, GDP‑compliant international pharmaceutical supplier serving pharmacies, hospitals, and clinics worldwide, adhering to stringent quality standards and regulatory requirements.

Nicotine Polacrilex is used in nicotine replacement therapy to address tobacco dependence.

- Smoking cessation: helps reduce nicotine withdrawal symptoms in adults who want to quit smoking. - Tobacco dependence: provides a controlled nicotine dose to support gradual reduction. - Relapse prevention: assists former smokers in maintaining abstinence during the quitting process.

Nicotine Polacrilex may cause a range of adverse reactions, most of which are mild and transient.

Common Side Effects: - Mouth irritation: mild soreness or tingling of the oral mucosa. - Nausea: occasional upset stomach or feeling of queasiness. - Increased salivation: excess saliva production in the mouth. - Dysgeusia: altered taste sensation, often described as metallic.

Serious or Rare Side Effects: - Anaphylactic reaction: severe allergic response requiring immediate medical attention. - Chest pain: possible cardiac discomfort that should be evaluated promptly. - Oral ulceration: painful sores in the mouth that may need treatment.

When using Nicotine Polacrilex, certain precautions should be observed to ensure safe and effective therapy.

- Assess nicotine dependence level: evaluate the patient’s smoking history and dependence before initiating therapy. - Avoid concurrent nicotine products: do not combine with other nicotine replacement therapies to prevent overdose. - Monitor cardiovascular status: advise patients with heart disease to consult their physician before use. - Contraindicated in children and adolescents: not indicated for individuals under 18 years of age. - Store at ambient temperature: keep in the original packaging, protect from moisture and heat.

Nicotine Polacrilex can interact with other medicines; awareness of these interactions helps minimize risk.

Major Interactions (Avoid): - Monoamine oxidase inhibitors (MAOIs): may amplify nicotine’s sympathomimetic effects, increasing blood pressure. - CYP2A6 inhibitors: can raise nicotine plasma concentrations, heightening side‑effect risk. - Other nicotine replacement products: concurrent use can lead to nicotine toxicity.

Moderate Interactions (Monitor Closely): - Caffeine: nicotine may enhance caffeine‑induced jitteriness; monitor stimulant intake. - Alcohol: combined use may increase cravings and affect nicotine metabolism. - Selective serotonin reuptake inhibitors (SSRIs): observe for mood changes or increased anxiety.